Researchers develop nasal vaccine offering wide protection against viruses and bacteria in mice
Researchers develop nasal vaccine offering wide protection against viruses and bacteria in mice is drawing significant interest across the industry.
Stanford Medicine researchers have developed a novel nasal vaccine that provides mice with broad protection against respiratory viruses, bacteria, and allergens. This innovative approach mimics immune cell communication signals, integrating innate and adaptive immunity for sustained, wide-ranging defense. The vaccine offers a promising step towards a universal respiratory vaccine, potentially simplifying annual immunizations and preparing for future pandemics.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- 'Dhurandhar 2': Ranveer Singh announces the trailer date of the much-awaited sequel as film gets a solo release on EID
- 'We Are Very Much Wedded To Strategic Autonomy': EAM Jaishankar On India's Energy Choices At Munich Security Conference
- Harbinger acquires autonomous driving company Phantom AI
- Bail for 9 as pre-trial custody irks court
Source: Original →